1. Home
  2. EDIT vs CLAR Comparison

EDIT vs CLAR Comparison

Compare EDIT & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • CLAR
  • Stock Information
  • Founded
  • EDIT 2013
  • CLAR 1957
  • Country
  • EDIT United States
  • CLAR United States
  • Employees
  • EDIT N/A
  • CLAR N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • EDIT Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • EDIT Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • EDIT 156.5M
  • CLAR 150.4M
  • IPO Year
  • EDIT 2016
  • CLAR N/A
  • Fundamental
  • Price
  • EDIT $2.25
  • CLAR $3.51
  • Analyst Decision
  • EDIT Buy
  • CLAR Strong Buy
  • Analyst Count
  • EDIT 13
  • CLAR 4
  • Target Price
  • EDIT $6.73
  • CLAR $5.50
  • AVG Volume (30 Days)
  • EDIT 2.4M
  • CLAR 120.8K
  • Earning Date
  • EDIT 08-06-2025
  • CLAR 07-31-2025
  • Dividend Yield
  • EDIT N/A
  • CLAR 2.87%
  • EPS Growth
  • EDIT N/A
  • CLAR N/A
  • EPS
  • EDIT N/A
  • CLAR N/A
  • Revenue
  • EDIT $35,837,000.00
  • CLAR $255,437,000.00
  • Revenue This Year
  • EDIT N/A
  • CLAR N/A
  • Revenue Next Year
  • EDIT N/A
  • CLAR $4.23
  • P/E Ratio
  • EDIT N/A
  • CLAR N/A
  • Revenue Growth
  • EDIT N/A
  • CLAR N/A
  • 52 Week Low
  • EDIT $0.91
  • CLAR $3.02
  • 52 Week High
  • EDIT $6.05
  • CLAR $6.83
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 63.76
  • CLAR 57.66
  • Support Level
  • EDIT $2.05
  • CLAR $3.45
  • Resistance Level
  • EDIT $2.55
  • CLAR $3.59
  • Average True Range (ATR)
  • EDIT 0.23
  • CLAR 0.11
  • MACD
  • EDIT 0.03
  • CLAR 0.02
  • Stochastic Oscillator
  • EDIT 66.29
  • CLAR 81.63

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: